Cohance Lifesciences Limited
COHANCE
Rang in aandelen
#6386
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Aandeelprijs
$5.05
Laatst gesynchroniseerd: 2026-10-19
Marktkapitalisatie
$1.93B
Verandering (1 dag)
-1.44%
Verandering (1 jaar)
-57.38%
Land
IN
Handel Cohance Lifesciences Limited (COHANCE)
Categorie
Healthcare
Dividendrendementgeschiedenis voor Cohance Lifesciences Limited (COHANCE)
Het dividendrendement (TTM) van Cohance Lifesciences Limited (aandelsymbool: COHANCE) per 2024-03-31 is: 0.00%
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.51%
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.51%
Dividendrendementgeschiedenis van Cohance Lifesciences Limited (COHANCE) van 2019 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
| Jaar | Dividendrendement | Wijzigen |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | -100.00% |
| 2023 | 1.69% | 160.00% |
| 2022 | 0.65% | 225.00% |
| 2021 | 0.20% | -93.33% |
| 2020 | 3.00% | 455.56% |
| 2019 | 0.54% | 0.00% |
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
| Bedrijf | Dividendrendement | Land |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
